Skip to main content

Integral Health Asset Management, LLC

Position in TARS — Tarsus Pharmaceuticals, Inc.

CIK 1773206 New York, NY

Position in TARS

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$14,030,000
-$2,346,000 QoQ
Shares Held
200,000
0.0% QoQ
Ownership
0.456%
of shares outstanding
% of Portfolio
0.75%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2023
10 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TARS Over Time

Shares Held

Position Value (USD)

Derivatives in TARS

reported options exposure · as of Jun 30, 2024
CallValue
$0
CallShares
0
PutValue
$10,872,000
PutShares
400,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Integral Health Asset Management, LLC holds $1,502,601,600 across 54 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in TARS

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $14,030,000 200,000
2025-12-31 $16,376,000 200,000
2025-09-30 $14,857,500 250,000
2025-06-30 $8,102,000 200,000
2025-03-31 $10,274,000 200,000
2024-12-31 $19,379,500 350,000
2024-09-30 $12,333,750 375,000
2024-06-30 $10,872,000 400,000
2024-06-30 $16,036,200 590,000
2024-03-31 $21,446,500 590,000
2023-12-31 $2,025,000 100,000